as on October 17, 2025 at 1:29 am IST
Day's Low
Day's High
4.13%
Downside
6.10%
Upside
52 Week's Low
52 Week's High
79.33%
Downside
8.43%
Upside
Check Taysha Gene Therapies Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
-0.336
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.85
Industry PE ratio
-0.32286624203821657
PEG Ratio
0EBITDA
-88.0M
Revenue (TTM)
8.1M
Profit Margin
0.00%
Return On Equity TTM
0.00%
Track how Taysha Gene Therapies Inc P/E has moved over time to understand its valuation trends.
Taysha Gene Therapies Inc in the last 5 years
Lowest (-12.87x)
September 30, 2025
Today (-3.85x)
October 16, 2025
Industry (-0.32x)
October 16, 2025
Highest (15.33x)
December 31, 2023
Today’s Price to Earnings Ratio: -3.85x
Compare market cap, revenue, PE, and other key metrics of Taysha Gene Therapies Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.4B | -75.5% | -3.85 | 0.00% | |
BUY | $61.5B | 223.43% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $105.7B | 87.04% | 28.99 | 31.86% | |
BUY | $59.6B | -3.89% | 14.07 | 31.37% |
The Taysha Gene Therapies Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Taysha Gene Therapies Inc investment value today
Current value as on today
₹2,54,893
Returns
₹1,54,893
(+154.89%)
Returns from Taysha Gene Therapies Inc Stock
₹1,50,246 (+150.25%)
Dollar Returns*
₹4,647 (+4.65%)
Based on 16 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Taysha Gene Therapies Inc. Average target price of $9.5
Get share price movements and forecasts by analysts on Taysha Gene Therapies Inc.
What analysts predicted
46.53%UPSIDE
Target Price
$9.5
Current Price
$5.08
Analyzed by
16 Analysts
Target
$9.50
Taysha Gene Therapies Inc target price $9.5, a slight upside of 46.53% compared to current price of $5.08. According to 16 analysts rating.
Investment in Taysha Gene Therapies Inc Shares on INDmoney has grown by 1975.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:1975.00% versus previous 30 day period
Search interest for Taysha Gene Therapies Inc Stock has increased by 1067% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1067% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, TSHA stock has moved up by 84.1%
Best in 3 Years
In the last 3 years, TSHA has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
In the last 1 year, TSHA has outperformed top 5 stocks with highest market-cap in its industry
Organisation | Taysha Gene Therapies Inc |
Headquarters | 3000 Pegasus Park Drive, Dallas, TX, United States, 75247 |
Industry | Health Technology |
CEO | Mr. Sean P. Nolan |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Frederick Porter Ph.D. | Chief of Staff & Technical Operations Officer |
Mr. Sean McAuliffe | Chief Business Officer |
Dr. Steven Gray Ph.D. | Chief Scientific Advisor of UT Southwestern Gene Therapy Program |
Mr. Sean P. Nolan | CEO & Chairman |
Dr. Sukumar Nagendran M.D. | President, Head of Research & Development and Director |
Mr. Kamran Alam CPA, M.B.A. | CFO & Corporate Secretary |
Hayleigh Collins | Director of Corporate Communications & Investor Relations |
Ms. Tracy M. Porter SPHR | Chief People Officer |
Ms. Emily McGinnis M.P.H. | Chief Patient & External Affairs Officer |
Berge Minassian M.D. | Chief Medical Advisor of UT Southwestern Gene Therapy Program |
Taysha Gene Therapies Inc share price today is $5.08 as on at the close of the market. Taysha Gene Therapies Inc share today touched a day high of $5.39 and a low of $4.87.
Taysha Gene Therapies Inc share touched a 52 week high of $5.51 on and a 52 week low of $1.05 on . Taysha Gene Therapies Inc stock price today i.e. is closed at $5.08,which is 7.77% down from its 52 week high and 383.81% up from its 52 week low.
Taysha Gene Therapies Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Taysha Gene Therapies Inc (TSHA) shares with as little as ₹87.83 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.30 in Taysha Gene Therapies Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Taysha Gene Therapies Inc share’s latest price of $5.08 as on October 17, 2025 at 1:29 am IST, you will get 1.9685 shares of Taysha Gene Therapies Inc. Learn more about
fractional shares .
Taysha Gene Therapies Inc stock has given -75.5% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?